WC
BBIO icon

Whitney & Co’s BridgeBio Pharma BBIO Stock Holding History

Whitney & Co’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,000
Closed -$451K – 177
2025
Q4 		$451K Sell
9,000
-3,000
-25% -$197K 0.04% 124
2025
Q3 		$305K Hold
12,000
– – 0.03% 117
2025
Q2 		$225K Hold
12,000
– – 0.02% 126
2025
Q1 		$142K Buy
+12,000
New +$405K 0.02% 128

Other funds holding BBIO

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Whitney & Co's BBIO Position: Q2 2026 in Review

Whitney & Co held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 5,050 shares worth $376K. The position accounts for 0.03% of the portfolio, ranked #136.

Whitney & Co first reported a position in BBIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $393K in Q2 2025. 95 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Whitney & Co held 5,050 shares of BridgeBio Pharma worth $376K as of Q2 2026.
  • Whitney & Co left its BridgeBio Pharma share count unchanged in Q2 2026.
  • BridgeBio Pharma made up 0.03% of Whitney & Co's portfolio in Q2 2026, its #136 holding.
  • Whitney & Co first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 6 quarters since.
  • Whitney & Co's BridgeBio Pharma position peaked at $393K in Q2 2025.
  • 95 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Whitney & Co's 13F filing for Q2 2026, filed 28 Jul 2026.